(Fully Booked) Wuxi Business Delegation: Exploring Synergies in Food Processing & Pharmaceuticals

Bühler Group 布勒集团 

Pfizer pharmaceutical（Wuxi） 辉瑞制药（无锡）有限公司

Company Profile:

Billions of people come into contact with Bühler technologies to cover their basic needs for food and mobility every day. Bühler develops the best process solutions along complete value chains. Bühler has two business pillars: Grains & Food solutions ensure safe and healthy food and feed. Advanced Materials contributes to the production of energy-efficient vehicles and buildings. As a Swiss company with a history of more than 160 years, Bühler is active in 140 countries around the world and operates a global network of 105 service stations, 27 manufacturing sites, and Application Centers in 26 locations globally. Bühler invests up to 5% of turnover into research and development. In 2023, 12,000 employees generated a turnover of CHF 2.8 billion. 

公司简介：

每天，数以亿计的人们都在享用布勒技术，满足自己在食品和交通出行领域的日常所需。布勒致力于在整个价值链中开发卓越的工艺解决方案，拥有两大业务支柱：谷物食品解决方案，确保安全和健康的食品与饲料；先进材料解决方案，致力于生产节能车辆和建造节能建筑。作为一家拥有160多年历史的瑞士企业，布勒活跃于全球140个国家，拥有包含27个生产基地和105家客户服务中心的全球网络，同时在全球26个地区拥有应用与培训中心。每年布勒将营业额的5%用于研发。2025年，来自于布勒全球的12,000 多名员工创造了28亿瑞士法郎的销售额。

Company Profile:

Pfizer pharmaceutical (Wuxi) company limited was established in September 1995. As a key member of Pfizer's global manufacturing network, Pfizer Wuxi is committed to its long-term promise of "In China, For China." Leveraging world-class technologies, quality standards and operational excellence, the site continues to create value for patients and contribute to China's biopharmaceutical industry

Wuxi Plant adheres to the concept of'Science Will Win' and its main products are Pharmorubicin, Zavedos, Cytosar and Zithromax.

To better meet the growing healthcare needs of patients in China, the Wuxi Plant has continuously strengthened its manufacturing capabilities. Based on the needs of the Chinese market, the Freeze Dryer and Filling Line with advanced isolator technology was officially launched. The project incorporates world-class isolator technology and fully automated manufacturing processes, enabling end-to-end aseptic control throughout production. This significantly enhances product quality, reliability, and patient safety while supporting the sustainable development of China's healthcare industry.

Inspired by Pfizer's purpose of delivering breakthroughs that change patients' lives, Pfizer Wuxi upholds the highest standards of quality, safety and value. Through advanced manufacturing technologies, robust quality systems and digital innovation, the site supports the Healthy China initiative, improves access to medicines, and benefits more patients.

公司简介：

辉瑞制药（无锡）有限公司成立于1995年9月，是辉瑞公司投资设立的独资企业，是一家以科学为基础的，以患者为先的生产基地。作为辉瑞全球生产网络的重要组成部分，辉瑞无锡始终坚持"扎根中国、服务中国"，致力于将全球先进的生产技术、质量标准和管理经验与中国市场需求相结合，持续为患者健康创造价值，为生物医药产业高质量发展贡献力量。

辉瑞无锡主要生产法玛新、善唯达、赛德萨和希舒美产品。

辉瑞无锡积极推进中国健康事业，基于市场需求，引进了当前最现代的无菌冻干生产线。该生产线采用目前先进的隔离器技术，全自动化生产，实现无菌制剂生产全过程的无菌控制,最大程度地保证产品质量。

秉承"为患者带来改变其生活的突破创新"使命，辉瑞无锡始终奉行严格的质量、安全和价值标准，持续推动先进生产技术、质量管理体系及数字化实践在本土落地，积极推动"健康中国"建设，提高产品可及性，惠及更多患者。